Results 211 to 220 of about 26,548 (293)

Mineralocorticoid Receptor Antagonist Pre-Adrenalectomy in Primary Aldosteronism.

J Clin Endocrinol Metab
Goi J, Paja Fano M, Rizo Gellida A, González-Boillos M, Martín Rojas-Marcos P, Caja Guayerbas L, García Cano AM, Ruiz-Sanchez JG, Vicente A, Gómez-Hoyos E, Recasens M, Barahona San Millan R, Picón César MJ, Díaz Guardiola P, Perdomo CM, Manjón-Miguélez L, Rebollo Román Á, Robles Lázaro C, Recio-Cordova JM, Calatayud M, Jiménez López N, Sampedro Nuñez M, Mena Ribas E, Sanmartín Sánchez A, Gonzalvo Diaz C, Lamas C, Serrano J, Michalopoulou T, Tenes Rodrigo S, Pascual-Corrales E, Jaén Aguila F, Muñoz Rivas N, Moya Mateo EM, Gutiérrez-Medina S, Hanzu FA, Parra Ramírez P, Araujo-Castro M.   +36 more
europepmc   +1 more source

Management Strategies for Potassium Levels During Non-steroidal Mineralocorticoid Receptor Antagonist Therapy: A Comprehensive Review. [PDF]

Electrolyte Blood Press
Son HE.
europepmc   +1 more source

Standardizing the Clinical Approach to Cancer Therapy‐Related Cardiac Dysfunction: Applying Cardio‐Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers

Cancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Introduction and Methods Cancer therapy–related cardiac dysfunction (CTRCD) is a well established and potentially life‐threatening complication of contemporary oncologic treatment. Although comprehensive cardio‐oncology guidelines have been developed, their integration into routine hematology and oncology practice remains inconsistent.
Abdelrahman Ali, Suparna C. Clasen, Anne Blaes, Stephen Casselli, Anita Deswal, Susan Halli Demeter, Gregory Durm, Anecita Fadol, Alessandra Ferrajoli, Michael G. Fradley, Joerg Herrmann, Borja Ibanez, Sue Koob, Bogda Koczwara, Kasey J. Leger, Jennifer E. Liu, Teresa López‐Fernández, Alexander R. Lyon, N. G. Choon Ta, John Teerlink, Eric H. Yang, Susan Dent, Daniel Lenihan   +22 more
wiley   +1 more source

Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta-Analysis. [PDF]

J Am Heart Assoc
Huang CW, Huang TY, Yang YF, Chang LY, Tu YK, Wu VC, Chen JY.   +6 more
europepmc   +1 more source

Eplerenone inhibits atrial fibrosis in mutant TGF-β1 transgenic mice [PDF]

, 2016

core   +1 more source

A Case of Heart Failure With Reduced Ejection Fraction Secondary to Dilated Cardiomyopathy due to Long‐Standing Untreated Acromegaly: A Case Report and Focused Literature Review

Clinical Case Reports, Volume 14, Issue 4, April 2026.
Echocardiographic findings in dilated cardiomyopathy secondary to untreated acromegaly. (A) Apical four‐chamber view showing biventricular and biatrial dilation. (B‐C) Colour Doppler demonstrating mitral, aortic, and tricuspid regurgitation. (D) Reduced global longitudinal strain (GLS: −6.5%), consistent with severe systolic dysfunction.
Cristian Orlando Porras Bueno, Nancy Muriel Herrera Leaño, María Juliana Soto Chávez, Darío Parra Prieto, Alejandro Mariño Correa   +4 more
wiley   +1 more source

Non-steroidal mineralocorticoid receptor antagonist finerenone inhibits peritoneal fibrosis induced by high-glucose dialysate via regulating enhancer of zeste homolog 2 (EZH2) expression. [PDF]

Ren Fail
Chen D, Shu J, Zhang X, Wang S, Sun J, Chong N, Sun Z, Xu Y, Wang Q.   +8 more
europepmc   +1 more source

The Role of Inspiratory Muscle Strength in Functional Capacity and Left Atrial Strain in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction

Clinical Cardiology, Volume 49, Issue 4, April 2026.
In patients with HFpEF and HFmrEF, maximal inspiratory pressure is independently associated with exercise capacity, including peak oxygen uptake and 6‐minute walk distance, as well as left atrial reservoir strain. These findings highlight inspiratory muscle strength as a relevant functional determinant of exercise intolerance, independent of age and ...
Huu Dat Tran, Thi Ha Le, Thi Hoai Thu Bui, Duc Dung Doan, Thi Kim Lien Nguyen   +4 more
wiley   +1 more source

Addition of Sacubitril/Valsartan to Mineralocorticoid Receptor Antagonist Therapy in Primary Aldosteronism: Effects on Plasma Aldosterone Concentration and Plasma Renin Activity. [PDF]

J Clin Med Res
Okamura K, Matsushima M, Takamiya Y, Okuda T, Sako H, Udo A, Taniguchi K, Morisaki S, Imamura I, Urata H, Miura SI.   +10 more
europepmc   +1 more source

Prognostic Value of HALP Score in Rheumatic Mitral Stenosis: A Long‐Term Follow‐up Study

Clinical Cardiology, Volume 49, Issue 4, April 2026.
In 169 patients with rheumatic mitral stenosis, a low HALP score was associated with increased long‐term MACCE risk. The HALP score showed modest predictive value (AUC 0.644) but was not an independent predictor. It may serve as a simple complementary tool for risk stratification alongside established clinical parameters.
Ahmet Ferhat Kaya, Görkem Ayhan, Veysi Can, Emrah Özbek, Lezgin Dursun, Ömer Kümet   +5 more
wiley   +1 more source